IDEAS home Printed from https://ideas.repec.org/a/spr/hecrev/v11y2021i1d10.1186_s13561-021-00329-9.html
   My bibliography  Save this article

Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review

Author

Listed:
  • Celia Gutiérrez Villegas

    (IDIVAL, Research Institute Marqués de Valdecilla. C/ Cardenal Herrera Oria s/n)

  • María Paz-Zulueta

    (University of Cantabria
    IDIVAL, GI Derecho Sanitario y Bioética, GRIDES. C/ Cardenal Herrera Oria s/n. C.P)

  • Manuel Herrero-Montes

    (University of Cantabria
    IDIVAL, Grupo de Investigación en Enfermería. C/ Cardenal Herrera Oria s/n. C.P)

  • Paula Parás-Bravo

    (University of Cantabria
    IDIVAL, Grupo de Investigación en Enfermería. C/ Cardenal Herrera Oria s/n. C.P)

  • María Madrazo Pérez

    (University of Cantabria)

Abstract

Background Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a high prevalence, and high morbidity associated with significant socioeconomic costs. Objective To carry out a systematic review of the literature to analyze the main cost studies associated with COPD, in order to determine the main factors that influence the costs of the disease. Methods Searches were conducted in PubMed, SCOPUS and Web of Science databases for cost studies on COPD published in English, between the years 2015 and 2020. The search terms were “COPD” OR “pulmonary disease, chronic obstructive”, “cost*” OR “cost of illness”, “economic impact” AND “burden of disease”. The inclusion criteria included the identification of reported cost of the disease, economic burden, medical care expenses or use resources for COPD, the methodology used, data sources, and variables studied. Results 18 publications were analyzed: 17 included direct health costs, 6 included direct non-medical costs, 12 analyzed indirect costs and two reported intangible costs. Most of the studies reported data for developed and European countries, with direct costs being the most studied. Trends were observed in multiple studies of direct and healthcare costs for European countries measured by patient and year, where the higher costs were associated with more severe COPD and a frequent history of exacerbations. The highest costs reported corresponded to hospitalizations and the associated pharmacological treatment. The importance of the loss of productivity and premature retirement within the profile of the COPD patient was also highlighted as the main generator of indirect costs of the disease. Conclusion COPD generates substantial costs for the health system, mainly related to moderate to severe stages and the exacerbations and complications entailed. It is important to strengthen health systems with monitoring, evaluation and health education models that allow these patients to remain stable to avoid decompensation and subsequent hospitalizations.

Suggested Citation

  • Celia Gutiérrez Villegas & María Paz-Zulueta & Manuel Herrero-Montes & Paula Parás-Bravo & María Madrazo Pérez, 2021. "Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review," Health Economics Review, Springer, vol. 11(1), pages 1-12, December.
  • Handle: RePEc:spr:hecrev:v:11:y:2021:i:1:d:10.1186_s13561-021-00329-9
    DOI: 10.1186/s13561-021-00329-9
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1186/s13561-021-00329-9
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1186/s13561-021-00329-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jason Foo & Sarah H Landis & Joe Maskell & Yeon-Mok Oh & Thys van der Molen & MeiLan K Han & David M Mannino & Masakazu Ichinose & Yogesh Punekar, 2016. "Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-15, April.
    2. Anees ur Rehman & Mohamed Azmi Ahmad Hassali & Sohail Ayaz Muhammad & Sabariah Noor Harun & Shahid Shah & Sameen Abbas, 2020. "The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(2), pages 181-194, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Aizhamal Tabyshova & Berik Emilov & Maarten J. Postma & Niels H. Chavannes & Talant Sooronbaev & Job F. M. van Boven, 2020. "Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review," IJERPH, MDPI, vol. 17(20), pages 1-13, October.
    2. Faraidoun Moradi & Mia Söderberg & Fazil Moradi & Bledar Daka & Anna-Carin Olin & Mona Lärstad, 2019. "Health perspectives among Halabja’s civilian survivors of sulfur mustard exposure with respiratory symptoms—A qualitative study," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-16, June.
    3. Anees ur Rehman & Mohamed Azmi Ahmad Hassali & Sohail Ayaz Muhammad & Sabariah Noor Harun & Shahid Shah & Sameen Abbas, 2020. "The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(2), pages 181-194, March.
    4. Anoma Santiworakul & Nitita Piya-amornphan & Netchanok Jianramas, 2021. "A Home-Based Multimedia Pulmonary Rehabilitation Program Improves Clinical Symptoms and Physical Performance of Patients with Chronic Obstructive Pulmonary Disease," IJERPH, MDPI, vol. 18(21), pages 1-11, October.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:hecrev:v:11:y:2021:i:1:d:10.1186_s13561-021-00329-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/13561 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.